FDA approves glucose monitoring system

The Food and Drug Administration recently approved the FreeStyle Libre Flash Glucose Monitoring System to be sold in the United States. The Libre is manufactured by Abbott and is currently only available overseas. The system allows patients to view blood sugar every minute of the day without pricking a finger. The device will be available […]

Eye disease screening recommendations

Adults who have no signs or risk factors for eye disease should get a baseline eye disease screening at age 40 according to recommendations by the American Academy of Ophthalmology. Age 40 is the age when early signs of eye disease and vision changes might begin to occur. The baseline screening will allow the ophthalmologist […]

Diabetics more likely to skip eye exams

Despite having a higher risk of developing serious eye diseases that could potentially rob them of their vision, nearly 60 percent of diabetics do not have yearly eye exams. Diabetics are at a greater risk of losing their vision to diabetic retinopathy and the disease can lead to additional blinding eye problems if not caught early and […]

Diabetes risk doubled with 2 sweet drinks daily

Regardless of whether you consume two or more 200 – milliliter servings of sugar sweetened drinks or artificially sweetened drinks on a daily basis, a recent study found that your risk of developing type 2 diabetes is almost doubled.  If your intake is more than 5 200 – milliliter servings a day then you have […]

Testing blood sugar with a contact lens

For diabetics who must endure blood testing to check their glucose levels, a pain-free method may soon be available in the form of a contact lens. Researchers at the University of Houston published results of a study in the journal Advanced Materials. Armed with the knowledge that glucose is present in blood as well as […]

Eylea effective for Diabetic Retinopathy

A two-year clinical trial has found that diabetic patients suffering from severe vision loss from diabetic macular edema benefit the most from receiving treatment with Eylea versus Avastin or Lucentis. Eylea was just approved for use by the FDA for treating diabetic macular edema patients last year. The study was conducted by the National Institutes […]

Lucentis beats lasers in treating diabetic retinopathy

A study funded by the National Eye Institute determined that Lucentis injections trumped laser therapy in treating proliferative diabetic retinopathy. The study results were published in the Journal of the American Medical Association online. 305 patients were included in the study with half of them receiving monthly Lucentis injections for three months and then only […]

Annual dilated eye exams crucial for diabetic patients

Diabetic patients are encouraged to get an annual dilated eye exam and with November being Diabetic Eye Disease Awareness Month, prevention strategies are being stressed. Diabetes is the leading cause of new cases of blindness in adults. Close monitoring by an eye care professional can help lessen diabetes’ impact on vision and with diabetics being […]

Eylea approved as diabetic retinopathy treatment

The FDA gave its approval for Eylea to be used in the treatment of diabetic retinopathy in patients with diabetic macular edema. Currently one third of diabetic patients over the age of 40 have some variation of the eye disease. Diabetic retinopathy with macular edema can cause abnormal blood vessels to form on the retina’s […]

Avastin more effective for diabetic macular edema

A recent study did a comparison of the three top drugs used to treat diabetic macular edema. Researchers took a look at Avastin, Eylea and Lucentis and while all three drugs were equally effective in improving vision in patients who had slight vision impairment, Eylea was found to be more effective in treating patients with […]